Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCC reversal of rivaroxaban and apixaban anticoagulation in healthy volunteers
NL-OMON37035Active, not recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Feb 2013
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Trial of Human prothrombin complex, rivaroxaban and apixaban in anticoagulant reversal (6 arms), sponsored by Amsterdam University Medical Center. Started Feb 2013; status: active, not recruiting.
02
Drugs
Human prothrombin complexrivaroxabanapixaban
03
Conditions
anticoagulant reversal
Beyond the preview
Go deeper on NL-OMON37035.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37035.